Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis

Biotechnic and Histochemistry

Volumn 85, Issue 2, 2010, Pages 133-147

  D'Andrea, M R ^a   Nagele, R G ^b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Alzheimer's disease; Amyloid plaque; Blood brain barrier; Dense core plaques; Diffuse plaques; Histopathology; Immunohistochemistry; Inflammation; Neuronal death

Indexed keywords

AMYLOID;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CHEMISTRY; CLASSIFICATION; EXTRACELLULAR SPACE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRACELLULAR SPACE; NECROSIS; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SENILE PLAQUE; AMYLOID PLAQUE;

AGED; ALZHEIMER DISEASE; AMYLOID; BLOOD-BRAIN BARRIER; BRAIN; EXTRACELLULAR SPACE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRACELLULAR SPACE; NECROSIS; NEURONS; SENILE PLAQUES; PLAQUE, AMYLOID;

EID: 77949446035     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520290903389445     Document Type: Article

References (41)

1. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD (1996) Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J. Neurosci. Res. 43: 190-202.
2. Bitting L, Naidu A, Cordell B, Murphy GMJ (1996) β-amyloid peptide secretion by a microglial cell line is induced by β-amyloid (25-35) and lipopolysaccharide. J. Biol. Chem. 271: 16084-16089.
3. Cataldo AM, Nixon RA (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc. Natl. Acad. Sci. USA 87: 3861-3865.
4. Clifford PM, Siu G, Kosciuk M, Levin E, Venkataraman V, D'Andrea MR, Nagele RG (2008) α7 Nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Aβ peptides and promotes cerebrovascular amyloid angiopathy. Brain Res. 1234: 158-171.
5. Clifford P, Zarrabi S, Siu G, Kinsler KJ, Kosciuk MJ, Venkataraman V, D'Andrea MR, Dinsmore S, Nagele RG (2007) Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 1142: 223-236
6. Coria F, Moreno A, Rubio I, Garcia MA, Morate E, Mayor FJ (1993) The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals. Neuropathol. Appl. Neurobiol. 19: 261-268.
7. D'Andrea MR (2002) Do plaques in Alzheimer's disease brains have similar origins and fates? Soc. Neurosci. 26: 55.
8. D'Andrea MR, Cole GM, Ard MD (2004) The microglial phagocytic role with specifi c plaque types in the Alzhemier disease brain. Neurobiol. Aging 25: 675-683.
9. D'Andrea MR, Nagele RG (2002) MAP-2 immunolabeling can distinguish diffuse from dense core amyloid plaques in Alzheimer's disease brains. Biotech. & Histochem. 77: 95-103.
10. D'Andrea MR, Nagele RG (2006) Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Cur. Pharmaceut. Design 12: 677-684.
11. D'Andrea MR, Nagele RG, Gumula NA, Reiser PA, Polkovitch DA, Hertzog BM, Andrade-Gordon P (2002a) Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci. Lett. 323: 45-49.
12. D'Andrea MR, Nagele R, Lee DHS, Wang H-Y (2002b) Targeting intracellular Aβ for Alzheimer's disease drug discovery. Drug Develop. Res. 56: 194-200.
13. D'Andrea MR, Nagele RG, Wang H-Y, Lee DHS (2002c) Epitope recovery immunohistochemical methods insure intracellular localization of Aβ42 within Alzheimer's disease pyramidal neurons. Neurosci. Lett. 333: 163-166.
14. D'Andrea MR, Nagele RG, Wang H-Y, Peterson PA, Lee DHS (2001a) Evidence that neurons accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38: 120-134.
15. D'Andrea MR, Reiser PA, Gumula NA, Hertzog BM, Andrade-Gordon P (2001b) Application of triple-label immunohistochemistry to characterize infl ammation in Alzheimer's disease brains. Biotech. & Histochem. 76: 97-106.
16. D'Andrea MR, Reiser PA, Polkovitch DA, Gumula NA, Branchide B, Hertzog BM, Schmidheiser D, Belkowski S, Gastard M, Andrade-Gordon P (2003) The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations. Neurosci. Lett. 342: 114-118.
17. Davis JB, McMurray HF, Schubert D (1992) The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophys. Res. Commun. 189: 1096-1100.
18. DeWitt DA, Perry G, Cohen M, Doller C, Silver J (1998) Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149: 329-340.
19. Dziewczapolski G, Glogowshi CM, Masliah E, Heinemann SF (2009) Deletion of the α7 nicotinic acetylcholine receptor gene improves cognitive defi cits and synaptic pathology in a mouse model of Alzheimer's disease. J. Neurosci. 29: 8805-8815.
20. Frautschy SA, Cole GM, Baird A (1992) Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am. J. Pathol. 140: 1389-1399.
21. Gatan E, Overmier BJ (1999) Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequelae. Neurosci. Biobehav. Rev. 23: 615-633.
22. Giulian D, Baker TJ, Shih LC, Lachman LB (1986) Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
23. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8: 2485-2490.
24. Griffi n WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: signifi cance in plaque evolution. J. Neuropathol. Exp. Neurol. 54: 276-281.
25. Griffi n WST, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Grahm DI, Roberts GW, Mrak RE (1998) Glial-neuronal interactions in Alzheimer's disease: The potential role of a "cytokine cycle" in disease progression. Brain Pathol. 8: 65-72.
26. Haga S, Ikeda K, Sato M, Ishii T (1993) Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by culture microglial cells. Brain Res. 601: 88-94.
27. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185
28. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J. Neuroimmunol. 24: 173-182.
29. Mackenzie IA, Hao C, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol. Aging 16: 797-804.
30. Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang H-Y (2003) Evidence for glial amyloid plaques in Alzheimer's disease. Brain Res. 971: 197-209.
31. Nagele RG, D'Andrea MR, Wang H-Y (2002) Intraneuronal accumulation of β-amyloid 1-42 is mediated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110: 199-211.
32. Paresce DM, Chung H, Maxfi eld FR (1997) Slow degradation of aggregates if the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272: 29390-29397.
33. Rogers J, Webster S, Lue L-F, Brachova L, Civin WH, Emmerling M, Shivers B, Walker D, McGeer P (1996) Infl ammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17: 681-686.
34. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
35. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RC, Younkin SG, Brunden KR (1995) Amyloid βprotein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging 16: 737-745.
36. Stalder M, Phinney A, Probst A, Sommer B, Staufenbiel M, Jucker M (1999) Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154: 1673-1684.
37. Stoll G, Jander S (1999) The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58: 233-247.
38. Wang H-Y, D'Andrea MR, Nagele RG (2002) Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells. Neurobiol. Aging 23: 213-223.
39. Wang H-Y, D'Andrea MR, Plata-Salaman CR, Lee DHS (2000a) Decreased α7 nicotinic acetylcholine receptor proteins in sporadic Alzheimer's disease brains. Alzheimer's Lett. 3: 215-218.
40. 1-42 binds to α7 nicotinic acetylcholine receptor with high affi nity: implications for Alzheimer's disease pathology. J. Biol. Chem. 275: 5626-5632.
41. Wolf HK, Buslei R, Schmidt-Kastner, R, Schmidt-Kastner PK, Pietsch T, Wiestler OD, Bluemcke I (1996) NeuN: a useful neuronal marker for diagnostic histopathology. J. Histochem. Cytochem. 44: 1167-1171.